On March 2, 2015, Dr. Andrew Mearns Spragg, General Manager of Jellagen, a medical technology company in the United Kingdom, and Ecz. Selçuk Haydanlı visited TÜBİTAK MAM KE in order to develop a joint project within the scope of EU Horizon 2020. Within the scope of the visit, Dr. Serdar Sezer, Deputy Director of TÜBİTAK MAM KE Institute, provided information about the projects carried out/planned in the medical field and the EU Horizon 2020 calls with private sector participation. Following the presentations of the projects open to possible cooperation, the company representatives visited TÜBİTAK MAM KE laboratories and received information about the relevant studies.
Share this News
For questions and suggestionsContact Us
Most Recent
TÜBİTAK MAM Participated in the Processes4Planet Partnership and Networking Day
At the event organized within the scope of the Horizon Europe Programme, leading research nations and industry representatives from Europe
TÜBİTAK MAM Showcased Its Scientific and Technological Expertise at the Turkey Plastic Waste Workshop
At the Turkey Plastic Waste Workshop, where the environmental, economic, and public health aspects of plastic waste were discussed, TÜBİTAK MAM presented scientific research from various disciplines...
TÜBİTAK Marmara Research Center (MAM) Will Be Hiring Both Experienced and Inexperienced Staff
TÜBİTAK Marmara Research Center (MAM) will be hiring both experienced and inexperienced staff to be employed at the center. Job postings numbered TBTK.MAM.A.2026-1, TBTK.MAM.A.2026-2, and TBTK.MAM.T.2026-1...
The Evaluation Process for Job Posting No. TBTK.MAM.2026.ADAY-1 Has Been Completed
The evaluation process for applications submitted for our job posting No. TBTK.MAM.2026.ADAY-1 has been completed, and the candidates eligible for the interview have been selected. You can view the results of your application. The interview schedule,...